Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Peab decontaminates soil for future development in Norra Djurgård City

Peab has been commissioned to decontaminate and stabilize contaminated soil in Norra Djurgård City in Stockholm. The customer is Stockholm City and the contract is worth SEK 140 million.Boberg Street will become the main street in the new residential area in Hjorthagen which will be built in stages and is part of Norra Djurgård City. The project includes decontaminating a total of around 220,000 m2 polluted earth, of which 55,000 m2 clay will be stabilized. The volumes are equal to around five soccer fields dug a meter deep. The decontaminated material will be used as filling and become the

Moberg Pharma announces the final terms of the fully guaranteed rights issue

On 6 November 2020, the board of directors of Moberg Pharma AB (publ) (OMX: MOB) (“Moberg Pharma” or the “Company”) announced that the board of directors had resolved to, subject to the approval of the extraordinary general meeting to be held on 1 December 2020 (the “EGM”), carry out a fully guaranteed rights issue of ordinary shares and warrants (“Units”) with preferential rights for existing shareholders in the amount of approximately MSEK 150 before transaction costs (the “Rights Issue”). The board of directors of Moberg Pharma today announces the final terms of the Rights Issue. Existing

Blue World Technologies invites smaller investors to join green tech adventure

Blue World Technologies is currently in the subscription phase with investors and have received commitments of more than 3 mEUR from European investors. Several of the investors have a history of investing in fuel cell technology. Smaller investors are also invited to join this unique investment opportunity. As the COVID-19 pandemic began spreading around the world at the beginning of the year, Blue World Technologies was in the process of closing an investment round that had been on the way for months. Terms and conditions were agreed on, but the uncertainties following the

Tipping point for the climate can already be a reality in East Asia

The climate in inner East Asia may already have reached a tipping point, where recent years’ transition to abnormally hot and dry summers can be irreversible. This is the finding of a new international study by researchers at University of Gothenburg now published in Science.Associated with the ongoing global warming, are changes that impact regional climate and ecosystems. In a worst- case scenario, these can reach what is known as a tipping point, at which point changes are fast and often times irreversible.  Examples of tipping points are the sea ice in the Arctic disappearing in the

More competitive manufacturing industry in Europe by extending component lifetime

Consortium led by VTT Technical Research Centre of Finland Ltd up scales novel material solution to extend lifetime of industrial components. Extended lifetime reduces material and energy losses enhancing competitiveness and productivity of Europe’s heavy industry, while lowering environmental impact of the manufacturing.    Wear leads to huge material and energy losses in industry causing 3% of the world’s total energy consumption. Wear-resistant coatings, such as tungsten carbide, WC-Co, coatings, enhance components’ durability leading to significant cost-savings. However,

Investments in southern Germany and Slovakia for further growth

The Lesjöfors company Stumpp + Schüle, with sites in Germany and Slovakia, has made important decisions for the future orientation of the company by further investments in the Slovakian site and in new software tools.Despite the major challenges that the Automotive supplier industry has faced throughout this year,  Stumpp + Schüle has continued to devote its capacities and resources to strengthen the future orientation for both sites from a strategic point of view and push ahead with its implementation. INVESTMENTS IN TOOLMAKING EXPERTISE Since 2019, Stumpp + Schüle s. r. o. in Nové

Interim report for the period 1 January – 30 September 2020

Baseload Capital Sweden AB (publ) today releases the results for the period 1 January – 30 September 2020   During the third quarter, development in each market has remained strong despite the current COVID-19 pandemic. Our project companies have experienced some delays in their projects, but work has largely been able to proceed as planned. · The result for the third quarter was SEK -7.0 million (SEK -22.6 million for the same period in 2019). For the 9 months ending 30 September 2020, the result was SEK -25.7 million (SEK -13.3 million for the same period in 2019). ·

Cloudberry Clean Energy AS | Withdrawal from potential M&A transaction

Oslo, Norway, 27 November 2020: Reference is made to the stock exchange notice dated 13 November 2020 (the “Stock Exchange Notice”) regarding Cloudberry Clean Energy AS’ (“Cloudberry” or the “Company”) engagement in a potential M&A transaction involving Nordic renewable assets.Cloudberry has over the last weeks participated in a structured sales process for potentially acquiring a Nordic independent power producer (IPP) (the “Transaction”). The Company has a strict policy of not compromising on its return requirements for producing and development assets, and the valuation gap between the

Nanoform Finland Plc, Interim Report January - September 2020, November 27[th], 2020 at 08:00 a.m. Finnish time

COMPANY RELEASE Nanoform Finland Plc, Interim Report January - September 2020, November 27[th], 2020 at 08:00 a.m. Finnish time Strong momentum continues: first GMP campaign initiated, first dosing in humans to start before year-end, all near-term business targets set out in IPO to be achieved ahead of schedule, new global major pharma client signed, two new PoC projects started, one more non-GMP line commissioned and a new near-term business target introduced: “First Biologics PoC project in 2021”.   7-9/2020 key financials: - Revenue was EUR 159 thousand, during 7-9/2019

Nanoform launches technology for biologics and sets new near-term business target for 2021

Inside information Nanoform Finland Plc November 27[th], 2020 at 07:50 a.m. Finnish time   Nanoform launches technology for biologics and sets new near-term business target for 2021 Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, today announced a proprietary technology that can form biological nanoparticles as small as 50 nm and announced a new near-term business target for 2021 to deliver its first biologics Proof of Concept project for this new technology with a pharmaceutical or biotech partner. As drug

Vestas wins 328 MW order for two wind projects in Australia

News release from Vestas Asia PacificSingapore, 26 November 2020 In partnership with Global Power Generation, a subsidiary of the multinational power company Naturgy Group, Vestas has secured a 328 MW deal for two wind projects in Victoria, Australia. The order includes supply and installation of 52 V136-4.2 MW wind turbines for the Ryan Corner Wind Farm as well as the engineering, procurement and construction of 26 V136-4.2 MW wind turbines for the second stage of Berrybank Wind Farm.  Both projects mark an important step towards building smarter, more liveable and emissions-free

Stabilization measures taken

Company announcement 14/2020     NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA OR CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL   This announcement does not constitute an offering circular or a prospectus as defined by Regulation (EU) No. 2017/1129 of 14 June 2017 and nothing herein shall be construed as an offering of securities.     With reference to the company announcement no. 5/2020 dated 18 November 2020

Bioservo has completed a directed issue of approximately SEK 14 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, AUSTRALIA OR ANY OTHER JURISDICTION, WHERE SUCH ACTIONS ARE SUBJECT TO LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES NOT MAKE AN OFFER REGARDING ANY SECURITIES IN BIOSERVO.The Board of Directors of Bioservo Technologies Aktiebolag (”Bioservo” or the ”Company”) has, pursuant to the authorization from the Annual General Meeting on May 7, 2020, resolved on a directed issue of 1,500,000 shares at a price of SEK 9.50 per share (the "Directed Issue"). The price in the

Interim report 1 January – 30 September 2020

The period July through September continued to be characterised by the negative impact of the corona pandemic on the entertainment and experience industry. During the quarter, net sales from operations totalled SEK 31 million (146), a reduction of almost 80%, which reflects the industry’s predicament under the severe restrictions imposed by the authorities. During the quarter, our focus was on preparations for reopening several venues, managing the strained liquidity situation and creating a more flexible cost base to render operations more efficient in the future.A WORD FROM THE CEO Up

Episurf Medical carries out a directed share issue and raises proceeds of SEK 66 million

This press release may not be made public, published or distributed, directly or indirectly, within or to the United States, Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, Singapore, South Africa or any other jurisdiction where such action would be unlawful or subject to legal restrictions.The Board of Directors of Episurf Medical AB (publ) (”Episurf Medical” or the ”Company”) has, based on the authorisation granted by the Annual General Meeting on 2 April 2020, resolved on a directed issue of 36,811,000 shares of series B at an issue price of SEK 1.80 per share (the “Share

2cureX publishes interim report for the third quarter of 2020.

2cureX AB (“2cureX”) hereby publishes interim report for the third quarter of 2020. The interim report is available as an attached document as well as on the company’s website (www.2curex.com). Below follows a short summary of the report.CEO Ole Thastrup comments “IndiTreat® was officially launched for colorectal cancer at the end of the third quarter at the international cancer conference ESMO (Eur. Soc. Medical Oncology). Nine months of pre-launch activities in 2020 embedded the launch readiness in terms of product offering, pricing, and positioning in our commercial strategy and

We are looking for a Key Account Manager for Eastern Norway to support our growth plan in Scandinavia

Kiilto er et familieeid selskap fra Finland etablert i 1919 med en visjon frem mot 2080. Vi utvikler, produserer og markedsfører kjemiske industriløsninger i fire forretningsområder: bygg, industriell binding, profesjonell hygiene og forbrukervirksomhet. De viktigste prinsippene for vår virksomhet er miljølederskap, nærhet og engasjement for fremtiden. Vi opererer i 11 land, og sysselsetter rundt 1000 mennesker. KiiltoClean AS produserer og selger hygieneløsninger på det nordiske markedet, og er markedsleder på desinfeksjons- og hygieneløsninger i Norge med Antibac®. Vi har 15 ansatte i

Bioservo is investigating the prerequisites for carrying out a directed share issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, AUSTRALIA OR ANY OTHER JURISDICTION, WHERE SUCH ACTIONS ARE SUBJECT TO LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES NOT MAKE AN OFFER REGARDING ANY SECURITIES IN BIOSERVO.Bioservo Technologies Aktiebolag (”Bioservo” or the ”Company”) has mandated Erik Penser Bank to investigate the prerequisites to carry out a directed issue of up to 1 500 000 new shares (the “Directed Issue”) through an accelerated bookbuilding procedure (the “Bookbuilding Procedure"). Through

Bulletin from Annual General Meeting of Diamyd Medical AB

The Annual General Meeting of Diamyd Medical AB (publ) was held on November 26, 2020. The Company's income statement and balance sheet were adopted, and the Board members and the Chief Executive Officer were discharged from liability for the fiscal year 2019/2020. The Annual General Meeting approved the Board's proposal that no dividend be paid for the fiscal year 2019/2020. Erik Nerpin was re-elected as Chairman of the Board and Anders Essen-Möller, Maria-Teresa Essen-Möller, Torbjörn Bäckström and Mark A. Atkinson were re-elected to the Board. The Annual General Meeting approved

2cureX launches new website

Copenhagen, November 26, 2020 – 2cureX is proud to announce the launch of its newly redesigned website at https://www.2curex.com/. The new site features a streamlined, modern design and improved functionality.The primary goal during the redesign process was to create a more valuable, user-centric and responsive resource across all platforms and devices. Specifically, the primary aim of the development of the improved website was to make it easier for a broader group of users to learn and locate valuable information about our IndiTreat test, clinical programs, important projects and

#20-428 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#20-427 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Peutinger AB owns 99.66 per cent of the shares in Internationella Engelska Skolan following completion of the public offer

THIS PRESS RELEASE IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT JURISDICTION WOULD BE PROHIBITED BY APPLICABLE LAW. SHAREHOLDERS NOT RESIDENT IN SWEDEN WHO WISH TO ACCEPT THE OFFER (AS DEFINED BELOW) MUST MAKE INQUIRIES CONCERNING APPLICABLE LEGISLATION AND POSSIBLE TAX CONSEQUENCES. SHAREHOLDERS SHOULD REFER TO THE OFFER RESTRICTIONS INCLUDED IN THE SECTION TITLED “IMPORTANT INFORMATION” AT THE END OF THIS

There are no items matching the current filter
There are no more items matching the current filter
Back to top